HU226413B1
(en)
|
1991-06-25 |
2008-11-28 |
Aventis Pharma Sa |
Novel 16-(nitro-substituted methyl)pregna-1,4-dien-3,20-dion derivatives and process for producing them
|
DE4127404A1
(de)
|
1991-08-19 |
1993-02-25 |
Thomae Gmbh Dr K |
Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US5491234A
(en)
|
1992-03-30 |
1996-02-13 |
Pfizer Inc. |
Pyrimidine derivatives for enhancing antitumor activity
|
WO2000012485A1
(en)
|
1998-08-29 |
2000-03-09 |
Astrazeneca Ab |
Pyrimidine compounds
|
EP2308833A3
(en)
|
1999-04-15 |
2011-09-28 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
DE10007411A1
(de)
|
2000-02-18 |
2001-08-23 |
Bayer Ag |
Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
AU2006201230B8
(en)
|
2000-09-15 |
2008-09-25 |
Vertex Pharmaceuticals Incorporated |
Triazole Compounds Useful As Protein Kinase Inhibitors
|
AU2006201265B2
(en)
|
2000-09-15 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazole Compounds Useful As Protein Kinase Inhibitors
|
EP1317449B1
(en)
|
2000-09-15 |
2006-05-31 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
AU2006201264A1
(en)
|
2000-09-15 |
2006-04-27 |
Vertex Pharmaceuticals Incorporated |
Pyrazole Compounds Useful As Protein Kinase Inhibitors
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
AU2006201263B2
(en)
|
2000-09-15 |
2008-10-30 |
Vertex Pharmaceuticals Incorporated |
Pyrazole Compounds Useful As Protein Kinase Inhibitors
|
AU2006201262B2
(en)
|
2000-09-15 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazole Compounds Useful As Protein Kinase Inhibitors
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
PT1347971E
(pt)
|
2000-12-21 |
2006-06-30 |
Bristol Myers Squibb Co |
Inibidores tiazolilicos de tirosina-cinases da familia tec
|
ES2265450T3
(es)
|
2000-12-21 |
2007-02-16 |
Vertex Pharmaceuticals Incorporated |
Compuestos de pirazol utiles como inhibidores de la proteina quinasa.
|
AU2006201229B2
(en)
|
2000-12-21 |
2008-11-20 |
Vertex Pharmaceuticals Incorporated |
Pyrazole Compounds Useful as Protein Kinase Inhibitors
|
ATE430742T1
(de)
|
2000-12-21 |
2009-05-15 |
Smithkline Beecham Corp |
Pyrimidinamine als angiogenesemodulatoren
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
MEP13408A
(en)
|
2001-05-29 |
2010-06-10 |
Bayer Schering Pharma Ag |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
CA2465978C
(en)
|
2001-09-14 |
2015-04-07 |
Soon Hyung Woo |
Inhibitors of histone deacetylase
|
US7868204B2
(en)
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
AU2006252047B2
(en)
|
2001-09-14 |
2010-02-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
US7112587B2
(en)
|
2001-09-21 |
2006-09-26 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
US7173032B2
(en)
|
2001-09-21 |
2007-02-06 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
US7132423B2
(en)
|
2001-09-21 |
2006-11-07 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
US7163943B2
(en)
|
2001-09-21 |
2007-01-16 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
US7169785B2
(en)
|
2001-09-21 |
2007-01-30 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
WO2003026664A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Corporation |
2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
|
WO2003040141A1
(en)
|
2001-09-28 |
2003-05-15 |
Bayer Pharmaceuticals Corporation |
Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders
|
CA2463989C
(en)
|
2001-10-17 |
2012-01-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
|
ATE389638T1
(de)
|
2001-11-01 |
2008-04-15 |
Janssen Pharmaceutica Nv |
Aminobenzamidderivate als inhibitoren der glycogensynthasekinase-3-
|
AU2002363176B2
(en)
|
2001-11-01 |
2008-09-25 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
WO2003059913A1
(en)
|
2002-01-10 |
2003-07-24 |
Bayer Healthcare Ag |
Roh-kinase inhibitors
|
ATE381557T1
(de)
|
2002-01-23 |
2008-01-15 |
Bayer Pharmaceuticals Corp |
Rho-kinase inhibitoren
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
AU2003220970A1
(en)
|
2002-03-01 |
2003-09-16 |
Smithkline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
WO2003078426A1
(en)
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azolylaminoazine as inhibitors of protein kinases
|
WO2003078423A1
(en)
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Compositions useful as inhibitors of protein kinases
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
DK1534286T3
(da)
|
2002-07-29 |
2010-04-26 |
Rigel Pharmaceuticals Inc |
Fremgangsmåder til behandling eller forebyggelse af autoimmune sygdomme med 2,4-pyrimidindiamin-forbindelser
|
JP4183193B2
(ja)
|
2002-08-30 |
2008-11-19 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
含窒素芳香環誘導体
|
US20040209930A1
(en)
|
2002-10-02 |
2004-10-21 |
Carboni Joan M. |
Synergistic methods and compositions for treating cancer
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
CA2503715A1
(en)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Kinase inhibitors
|
NZ539823A
(en)
|
2002-11-28 |
2008-04-30 |
Schering Aktiengessellschaft |
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
US7109337B2
(en)
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
PL379330A1
(pl)
|
2002-12-20 |
2006-08-21 |
Pfizer Products Inc. |
Pochodne pirymidyny dla leczenia nienormalnego wzrostu komórek
|
US7514446B2
(en)
|
2003-02-20 |
2009-04-07 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
EP1781659B1
(en)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
CN100404536C
(zh)
|
2003-07-16 |
2008-07-23 |
詹森药业有限公司 |
作为糖原合酶激酶3抑制剂的***并嘧啶衍生物
|
PT1656372E
(pt)
|
2003-07-30 |
2013-06-27 |
Rigel Pharmaceuticals Inc |
Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina
|
WO2005013982A1
(en)
|
2003-08-06 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
DE60336646D1
(de)
|
2003-08-07 |
2011-05-19 |
Nat Health Research Institutes |
Indol-Verbindungen als Inhibitoren der Tubulin-Polymerisation zur Behandlung von angiogenesisbezogenen Erkrankungen
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
NZ585188A
(en)
|
2003-08-15 |
2011-09-30 |
Novartis Ag |
2,4-Pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
|
JP4755496B2
(ja)
|
2003-09-08 |
2011-08-24 |
中外製薬株式会社 |
ヒアルロン酸修飾物、及びそれを用いた薬物担体
|
JP4205543B2
(ja)
|
2003-09-09 |
2009-01-07 |
本田技研工業株式会社 |
小型船
|
EP1670787B1
(en)
|
2003-09-11 |
2012-05-30 |
iTherX Pharma, Inc. |
Cytokine inhibitors
|
WO2005026130A1
(en)
|
2003-09-18 |
2005-03-24 |
Novartis Ag |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
EP1683812B1
(en)
|
2003-11-14 |
2014-11-12 |
Chugai Seiyaku Kabushiki Kaisha |
Crosslinked polysaccharide microparticles and method for their preparation
|
PT1687297E
(pt)
|
2003-11-24 |
2014-09-18 |
Prometic Biosciences Inc |
Dímeros da triazina para o tratamento de doenças autoimunes
|
EP1694652A1
(en)
|
2003-12-19 |
2006-08-30 |
Rigel Pharmaceuticals, Inc. |
Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
JP2007532669A
(ja)
|
2004-04-13 |
2007-11-15 |
イカジェン インコーポレイテッド |
カリウムイオンチャネル調節剤としての多環式ピリミジン
|
EP1745402A2
(en)
|
2004-04-20 |
2007-01-24 |
Alexander Kantarovich |
Method and system for online embroidery data processing
|
US20060205945A1
(en)
|
2004-05-14 |
2006-09-14 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
EP1758887A1
(en)
|
2004-05-14 |
2007-03-07 |
Pfizer Products Incorporated |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
CA2566531A1
(en)
|
2004-05-18 |
2005-12-15 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
WO2006012502A2
(en)
|
2004-07-23 |
2006-02-02 |
Rigel Pharmaceuticals, Inc. |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
US20060058525A1
(en)
|
2004-09-01 |
2006-03-16 |
Rajinder Singh |
Synthesis of 2,4-pyrimidinediamine compounds
|
TW200612991A
(en)
|
2004-09-07 |
2006-05-01 |
Chugai Pharmaceutical Co Ltd |
Process for producing water-soluble hyaluronic acid modification
|
WO2006046355A1
(ja)
|
2004-10-28 |
2006-05-04 |
Sharp Kabushiki Kaisha |
冷蔵庫
|
GB2420559B
(en)
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
MY169441A
(en)
|
2004-12-08 |
2019-04-11 |
Janssen Pharmaceutica Nv |
2,4, (4,6) pyrimidine derivatives
|
EP1831216A2
(en)
|
2004-12-23 |
2007-09-12 |
Pfizer Products Inc. |
Heteroaromatic derivatives useful as anticancer agents
|
CA2590110C
(en)
|
2004-12-30 |
2014-06-03 |
Exelixis, Inc. |
Kinase modulators and method of use
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
BRPI0610514A2
(pt)
|
2005-04-05 |
2016-11-16 |
Pharmacopeia Inc |
composto, composição farmacêutica, e, método de tratamento de um distúrbio
|
DE102005016634A1
(de)
|
2005-04-12 |
2006-10-19 |
Merck Patent Gmbh |
Neuartige Aza-Hetercyclen als Kinase-Inhibitoren
|
US8227455B2
(en)
|
2005-04-18 |
2012-07-24 |
Rigel Pharmaceuticals, Inc. |
Methods of treating cell proliferative disorders
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
NZ563454A
(en)
|
2005-06-08 |
2011-03-31 |
Rigel Pharmaceuticals Inc |
2,4-diaminopyrimidine derivatives for inhibition of the JAK pathway
|
AU2006269321A1
(en)
|
2005-07-08 |
2007-01-18 |
Ipsen Pharma S.A.S. |
Ligands of melanocortin receptors
|
WO2007006926A2
(fr)
|
2005-07-11 |
2007-01-18 |
Sanofi-Aventis |
Nouveaux derives de 2,4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2007014198A1
(en)
|
2005-07-25 |
2007-02-01 |
Synta Pharmaceuticals Corp. |
1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders
|
US7486280B2
(en)
|
2005-08-04 |
2009-02-03 |
Uniplas Enterprises Pte, Ltd. |
Contoured capacitive touch control panel
|
KR100674813B1
(ko)
|
2005-08-05 |
2007-01-29 |
일양약품주식회사 |
N-페닐-2-피리미딘-아민 유도체 및 그의 제조방법
|
US20090118310A1
(en)
|
2005-08-09 |
2009-05-07 |
University Of Medicine And Dentistry Of New Jersey |
Activated Cdc42-associated kinase (ACK) as a therapeutic target for Ras-induced cancer
|
EP1940804A2
(en)
|
2005-10-14 |
2008-07-09 |
NeuroSearch A/S |
Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
MY167260A
(en)
|
2005-11-01 |
2018-08-14 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
JP2009518443A
(ja)
|
2005-12-06 |
2009-05-07 |
リゲル ファーマシューティカルズ インコーポレーティッド |
脂質を主材料とする担体に内封された、不溶性小分子治療剤の製剤
|
NL2000323C2
(nl)
|
2005-12-20 |
2007-11-20 |
Pfizer Ltd |
Pyrimidine-derivaten.
|
EP1966207A2
(en)
|
2005-12-21 |
2008-09-10 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
US20070141684A1
(en)
|
2005-12-21 |
2007-06-21 |
Pfizer Inc |
Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
|
DE102005062742A1
(de)
|
2005-12-22 |
2007-06-28 |
Bayer Schering Pharma Ag |
Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel
|
US7962290B1
(en)
|
2006-01-09 |
2011-06-14 |
Rigel Pharmaceuticals, Inc. |
Identification of pharmacophores from co-crystals of spleen tyrosine kinase (SYK) and SYK ligands
|
TW200736232A
(en)
|
2006-01-26 |
2007-10-01 |
Astrazeneca Ab |
Pyrimidine derivatives
|
EP1979329A2
(en)
|
2006-01-30 |
2008-10-15 |
Exelixis, Inc. |
4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and methods of use
|
ES2622493T3
(es)
|
2006-02-24 |
2017-07-06 |
Rigel Pharmaceuticals, Inc. |
Composiciones y métodos para la inhibición de la ruta de JAK
|
JP2009533378A
(ja)
|
2006-04-10 |
2009-09-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
2,4−ジアミノピリミジン誘導体及び癌の治療のためのそれらの使用
|
CN101058561B
(zh)
|
2006-04-19 |
2011-01-26 |
苏州爱斯鹏药物研发有限责任公司 |
用于抑制蛋白激酶的二苯脲衍生物及其组合物和用途
|
EP2020231A4
(en)
|
2006-04-26 |
2010-11-10 |
Ito En Ltd |
FAT ABSORPTION INHIBITORS
|
WO2007130933A2
(en)
|
2006-05-01 |
2007-11-15 |
Jeffrey W Bezanson |
Apparatuses, methods and systems for vector operations and storage in matrix models
|
MX2008015004A
(es)
|
2006-05-26 |
2008-12-05 |
Abbott Lab |
Inhibidores de cinasas de tipo polo.
|
US7460807B2
(en)
|
2006-05-31 |
2008-12-02 |
Kabushiki Kaisha Toshiba |
Image forming apparatus and method of controlling the apparatus
|
CN101506175A
(zh)
|
2006-06-15 |
2009-08-12 |
贝林格尔·英格海姆国际有限公司 |
作为蛋白激酶C-α抑制剂的2-苯氨基-4-(杂环基)氨基-嘧啶
|
CA2654852A1
(en)
|
2006-06-30 |
2008-01-03 |
Astrazeneca Ab |
Pyrimidine derivatives useful in the treatment of cancer
|
WO2008005538A2
(en)
|
2006-07-05 |
2008-01-10 |
Exelixis, Inc. |
Methods of using igf1r and abl kinase modulators
|
US8008307B2
(en)
|
2006-08-08 |
2011-08-30 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
|
DE102006041382A1
(de)
|
2006-08-29 |
2008-03-20 |
Bayer Schering Pharma Ag |
Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren
|
MX2009004019A
(es)
|
2006-10-19 |
2009-06-19 |
Signal Pharm Llc |
Compuestos heteroarilo, composiciones de los mismos, y uso de los mismos como inhibidores de proteina cinasa.
|
US20080119496A1
(en)
|
2006-11-16 |
2008-05-22 |
Pharmacopeia Drug Discovery, Inc. |
7-Substituted Purine Derivatives for Immunosuppression
|
CN101616895A
(zh)
|
2006-12-08 |
2009-12-30 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
JP5622393B2
(ja)
|
2006-12-15 |
2014-11-12 |
アブラクシスバイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
WO2008082537A2
(en)
|
2006-12-19 |
2008-07-10 |
The General Hospital Corporation |
Compounds for modulating integrin cd11b/cd18
|
WO2008079719A1
(en)
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Pyrimidine kinase inhibitors
|
CA2672960A1
(en)
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
EP1939185A1
(de)
|
2006-12-20 |
2008-07-02 |
Bayer Schering Pharma Aktiengesellschaft |
Neuartige Hetaryl-Phenylendiamin-Pyrimidine als Proteinkinaseinhibitoren zur Behandlung von Krebs
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
US20080214558A1
(en)
|
2007-03-01 |
2008-09-04 |
Supergen, Inc. |
Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
|
DK2134689T3
(da)
|
2007-03-16 |
2014-06-30 |
Scripps Research Inst |
Inhibitorer af fokal adhæsionskinase
|
WO2008118822A1
(en)
|
2007-03-23 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
WO2008118823A2
(en)
|
2007-03-26 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
WO2008124085A2
(en)
|
2007-04-03 |
2008-10-16 |
Exelixis, Inc. |
Methods of using combinations of mek and jak-2 inhibitors
|
CA2684470C
(en)
|
2007-04-16 |
2016-02-09 |
Hutchison Medipharma Enterprises Limited |
Pyrimidine derivatives
|
CN101289444B
(zh)
|
2007-04-16 |
2012-01-04 |
和记黄埔医药(上海)有限公司 |
一种嘧啶衍生物及其医药用途
|
EP2146779B1
(en)
|
2007-04-18 |
2016-08-10 |
Pfizer Products Inc. |
Sulfonyl amide derivatives for the treatment of abnormal cell growth
|
EP2162445B1
(en)
|
2007-06-05 |
2013-11-27 |
Takeda Pharmaceutical Company Limited |
Heterobicyclic compounds as kinase inhibitors
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
WO2009003136A1
(en)
|
2007-06-26 |
2008-12-31 |
Rigel Pharmaceuticals, Inc. |
Substituted pyrimidine-2, 4 -diamines for treating cell proliferative disorders
|
BRPI0814821A2
(pt)
|
2007-07-16 |
2015-02-03 |
Astrazeneca Ab |
Composto, composição farmacêutica, e, processo para preparar um composto
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
FR2919869B1
(fr)
|
2007-08-09 |
2009-09-25 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
US8440681B2
(en)
|
2007-08-28 |
2013-05-14 |
Irm Llc |
2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
|
WO2009028629A1
(ja)
|
2007-08-29 |
2009-03-05 |
Takeda Pharmaceutical Company Limited |
複素環化合物およびその用途
|
JP5600063B2
(ja)
|
2007-10-19 |
2014-10-01 |
セルジーン アビロミクス リサーチ, インコーポレイテッド |
ヘテロアリール化合物およびその使用
|
US7989465B2
(en)
|
2007-10-19 |
2011-08-02 |
Avila Therapeutics, Inc. |
4,6-disubstituted pyrimidines useful as kinase inhibitors
|
WO2009063240A1
(en)
|
2007-11-16 |
2009-05-22 |
Arrow Therapeutics Limited |
2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase
|
WO2009073153A2
(en)
|
2007-11-28 |
2009-06-11 |
Dana Farber Cancer Institute |
Small molecule myristate inhibitors of bcr-abl and methods of use
|
US20090142832A1
(en)
|
2007-11-29 |
2009-06-04 |
James Dalton |
Indoles, Derivatives, and Analogs Thereof and Uses Therefor
|
US8461147B2
(en)
|
2007-12-03 |
2013-06-11 |
Boehringer Ingelheim International Gmbh |
Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
|
LT2252300T
(lt)
|
2008-02-22 |
2017-02-10 |
Rigel Pharmaceuticals, Inc. |
2,4-pirimidindiaminų panaudojimas aterosklerozės gydymui
|
CA2717529A1
(en)
|
2008-03-11 |
2009-09-17 |
Cellzome Limited |
Sulfonamides as zap-70 inhibitors
|
EP2303861B1
(en)
|
2008-06-17 |
2014-04-23 |
AstraZeneca AB |
Pyridine compounds
|
PE20100087A1
(es)
|
2008-06-25 |
2010-02-08 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
US8445505B2
(en)
|
2008-06-25 |
2013-05-21 |
Irm Llc |
Pyrimidine derivatives as kinase inhibitors
|
DK2361248T3
(en)
|
2008-06-27 |
2019-01-14 |
Celgene Car Llc |
Heteroberl compounds and uses thereof
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
CN101684098A
(zh)
|
2008-09-24 |
2010-03-31 |
中国科学院上海药物研究所 |
一类5-脂氧酶抑制剂及其制备方法、药物组合物和应用
|
DE102008058501B4
(de)
*
|
2008-11-21 |
2011-11-10 |
Eisenmann Ag |
Verfahren zum Betreiben einer Anlage zur Herstellung von Bioethanol
|
EP2241555A1
(en)
*
|
2009-04-14 |
2010-10-20 |
Universita' Degli Studi Di Milano |
New RAC1 inhibitors as potential pharmacological agents for heart failure treatment
|
EP2552211A4
(en)
|
2010-03-26 |
2013-10-23 |
Glaxo Group Ltd |
INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
|
EP2552214A4
(en)
|
2010-03-26 |
2013-10-16 |
Glaxo Group Ltd |
PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
|
EP2571867B1
(en)
*
|
2010-05-21 |
2015-11-04 |
Noviga Research AB |
Novel pyrimidine derivatives
|
JP2012209902A
(ja)
|
2011-03-30 |
2012-10-25 |
Semiconductor Components Industries Llc |
入出力回路
|
EP2877464B1
(en)
*
|
2012-07-24 |
2016-08-24 |
Boehringer Ingelheim International GmbH |
N-cyclopropyl-n-piperidinyl-amide derivatives and their use as gpr119 modulators
|